The deal will allow Exo to integrate Medo's Sweep AI technology into its ultrasound platform, which will make point-of-care ultrasound available to a wider range of healthcare providers, the company said. Medo AI uses automated image acquisition and interpretation to help less experienced ultrasound users perform high-quality exams, according to Exo.

Exo recently launched Exo Works, a point-of-care ultrasound (POCUS) workflow software application. The company is also working on bringing a new handheld ultrasound device to market, it said.